Arcadia Biosciences, Inc. (RKDA) SEC Filings — 2024
18 SEC filings for Arcadia Biosciences, Inc. (RKDA) in 2024.
Filings
- Arcadia Biosciences Files 8-K — 8-K · Dec 11, 2024
- Arcadia Biosciences Reports Material Agreement & Control Change — 8-K · Dec 6, 2024
- Arcadia Biosciences Q3 2024 10-Q Filing — 10-Q · Nov 12, 2024
- Arcadia Biosciences Files 8-K/A Amendment on Director Changes — 8-K/A · Aug 23, 2024
- Arcadia Biosciences Files 10-Q for Q2 2024 — 10-Q · Aug 13, 2024
- Arcadia Biosciences Appoints New Directors, One Departs — 8-K · Aug 7, 2024
- Arcadia Biosciences Appoints New CEO, Dr. Lowe — 8-K · Jul 8, 2024
- Arcadia Biosciences Reports on Shareholder Vote — 8-K · Jul 1, 2024
- Arcadia Biosciences Acquires Full Control of Specialty Products Unit — 8-K · May 20, 2024
- Arcadia Biosciences Completes Full Acquisition of Specialty Products Unit — 8-K · May 17, 2024
- Arcadia Biosciences, Inc. DEF 14A Filing — DEF 14A · May 16, 2024
- Arcadia Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Arcadia Biosciences Files 8-K on Financials — 8-K · May 9, 2024
- Arcadia Biosciences, Inc. Files 10-K/A Amendment — 10-K/A · Apr 29, 2024
- Arcadia Biosciences Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- Arcadia Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Arcadia Biosciences Reports Officer & Director Changes, New Compensation — 8-K · Feb 14, 2024
- Sabby Volatility Fund Discloses 97,305 Share Stake in Arcadia Bio — SC 13G · Jan 3, 2024